Holocene Advisors, LP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1700574
New York, NY
Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,447,171
-$45,726,807 QoQ
Shares Held
180,849
-94.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Holocene Advisors, LP holds $100,418,965 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (5.4% of the industry book) .
All Filings in TEVA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,447,171 | 180,849 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $51,173,978 | 3,053,340 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,797,052 | 4,020,628 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $69,853,862 | 3,169,413 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,861,735 | 2,212,083 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $74,526,920 | 4,586,272 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $70,020,254 | 4,962,456 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $54,895,555 | 5,258,195 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $52,252,284 | 5,122,773 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||